Trans-Resveratrol May Protect Against Heart Attack Aftermath

Trans-Resveratrol May Protect Against Heart Attack Aftermath

ROME--In an unpublished study presented at a June meeting of the European Society for Free Radical Research(http://imoax1.unimo.it/~sfrr/), researchers from Creighton University in Omaha, Neb., found thattrans-resveratrol may protect the heart against arrhythmias following a heart attack. The product used in this study was Benicia, Calif.-based InterHealth Nutaceuticals Inc.'s Protykin^®.

In a laboratory setting, researchers conducted a three-week test on three sets of test animals: one group received 50 mg/kg per day of Protykin, the second received 100 mg/kg per day and the third received nothing as the control group. Both increased heart rate and ventricular fibrillation (chaotic heartbeat) were reduced 58 percent (for 50 mg/kg) and 75 percent (for 100 mg/kg), whereas the control group only experienced an 8-percent decrease. Additionally, Protykin-supplemented animals experienced a reduction in myocardial infarction (tissue death) and malonyldialdehyde (MDA), a byproduct of free radicals.

"This research clearly demonstrates that Protykin can be extremely effective in reducing the damage that can result from heart attack by reducing the presence of free radicals in the myocardium," stated DebasisBagchi, Ph.D., the study's lead researcher.